Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10,100 JPY | -0.93% | -4.94% | -21.86% |
Mar. 06 | Shares in Japan's Ain soar after activist fund Oasis buys 9.6% stake | RE |
Feb. 28 | Aeon Co. Plans to Merge Japan Drugstore Unit Welcia With Rival Tsuruha -- 2nd Update | DJ |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
- According to Refinitiv, the company's ESG score for its industry is poor.
Strengths
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.44 for the 2024 fiscal year.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- The opinion of analysts covering the stock has improved over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company does not generate enough profits, which is an alarming weak point.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Drug Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-21.86% | 3.21B | D | ||
-2.49% | 3.34B | D- | ||
+10.87% | 2.79B | - | ||
+4.58% | 2.53B | C+ | ||
-14.48% | 1.66B | - | ||
+10.60% | 1.4B | - | - | |
-19.03% | 972M | - | ||
-40.19% | 639M | - | - | |
-0.53% | 454M | - | D+ | |
-0.83% | 382M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 3391 Stock
- Ratings Tsuruha Holdings Inc.